Overweight Subject

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Overweight Subject trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT07331389

A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

The purpose of this study is to characterize the drug-drug intereaction of HDM1002 and metformin, empagliflozin, midazolam, valsartan, and warfarin in overweigh…

China111 participantsStarted 2025-09-24

Treatment: Metformin, Empagliflozin

All recent trials (29 shown)

CompletedNot Applicable

NCT04112251

Effects of COcoa Supplement in OBese Adolescent Subjects

Childhood obesity is a serious public health problem internationally. In addition to being associated with the early onset of chronic degenerative diseases such…

Mexico104 participantsStarted 2019-12-15

Treatment: Cocoa Flavonols Supplement

TerminatedPhase 1

NCT03764774

A Study of LY3463251 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability (side effects) of single (Part A) and multiple (Part B) doses of the study drug when it is…

United States118 participantsStarted 2018-12-06

Treatment: LY3463251, Placebo

Overweight Subject

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

All recent trials (29 shown)

Effects of COcoa Supplement in OBese Adolescent Subjects

A Study of LY3463251 in Healthy Participants

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

All recent trials (29 shown)

Effects of COcoa Supplement in OBese Adolescent Subjects

A Study of LY3463251 in Healthy Participants

A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subje…

Low Sugar Protein Pacing, Intermittent Fasting Diet in Men and Women

Safety Study of LLF580 in Obese Volunteers

Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome

Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes

Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

Investigating the Role of Ghrelin in Regulating Appetite and Energy Intake in Patients Following Bariatric Surgery (BARI…

Transcranial Random Noise Stimulation in Food Addiction Treatment

Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects

Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients

Protein Need and Interest of " Quick Proteins " to the Obese Subject Operated by Bariatric Surgery (BIBOP)

Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ -…

Analysis of Immune Response In Bacterial Infection of Obese Subject

The USGI Medical ESSENTIAL Study for Weight Loss

Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033

The Effects of Flaxseed Supplement on Weight and Biochemical Factors in Overweight and Obese Subject

Effects of High Oleic Palm Olein, Virgin Olive Oil and Coconut Oil Diets on Markers Selected in Malaysian

Chronic Conditions in Childhood Obesity Subject: An Mixed Methods Research Approach